UK data - BRC Shop Price Index for September: 0.2% y/y (prior +0.1%)

MU jumps 90% on AI demand, trades at 5.5x forward earnings. OPRA up 31%, trades at 15x earnings. Both offer value.

ENR's 16.3% rally faces flat revenue forecasts. Peers surge, but ENR's valuation at $19.60 vs $21 target hints caution.

Medicare costs rise unpredictably, unlike Social Security. Plan for higher premiums & deductibles.

Cerebras eyes $26.6B valuation in IPO, pricing shares $115-$125 amid AI chip boom.

NSSC revenue in line, but EPS misses. Adjusted EBITDA beats, margins mixed. Stock up 6%.

CVX up 25% YTD on Mideast conflict & Iraq oil fields. Huge reserves found, but long-term impact uncertain.

CRC faces earnings pressure; revenue down 13.8% YoY. Analysts eye 6% growth, but past misses loom. Buy target $81.17 vs $68.37.